Eka Ventures has closed Fund II at £80 million ($107 million) to back up to 30 UK pre-seed and seed-stage companies, with initial investments typically around £1.6–2 million per company.

Fund II maintains Eka’s thesis of consumer tech at the intersection of preventive healthcare, sustainable consumption, and expanding access to essential services, continuing its impact-focused UK strategy.

The British Business Bank contributed £40 million as a cornerstone through its Enterprise Capital Funds program, signaling strong government-backed support for the UK impact economy.

Dolan highlights the importance of diverse, overlooked founders, citing Murvah Iqbal of Hived as an example of exceptional leadership and potential.

The investment thesis remains unchanged: consumer tech that enables preventive healthcare, sustainable consumption, and access to housing, insurance, and education.

Officials emphasize the UK’s talent, job creation, productivity, and driving economic growth as outcomes of the commitment.

Eka uses an in-house data platform to source deals, evaluating about 10,000 startups annually down to around 1,000, and applies a social objectives clause to ensure mission alignment.

Eka asserts that impact and returns are complementary, not trade-offs, fueling opportunities for the next decade.

Co-founding Partner Jon Coker stresses investing in startups that address societal needs while delivering sizable market opportunities.

The firm believes commercial and societal returns can compound, reinforcing the growth of UK impact investing.

Dolan remains optimistic about the sector’s trajectory despite funding headwinds, believing Eka’s portfolio can unlock abundant opportunity.

Portfolio highlights include Runna, Urban Jungle, Axle, Hived, Foresight Data Machines, Jude, and Flok Health, with some attracting follow-ons from major firms.